Valued Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Valued Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.4K	Sell	652 -16	-2%	-$2.11K	0.03%	83
2026 Q1	$93.1K	Sell	668 -43	-6%	-$6.02K	0.04%	65
2025 Q4	$87.3K	Buy	711 +79	+13%	+$9.6K	0.04%	63
2025 Q3	$70.2K	Buy	632 +29	+5%	+$3.3K	0.03%	67
2025 Q2	$66.8K	Buy	603 +32	+6%	+$3.41K	0.03%	67
2025 Q1	$64K	Sell	571 -58	-9%	-$5.99K	0.04%	76
2024 Q4	$58.1K	Buy	629 +310	+97%	+$27.9K	0.04%	76
2024 Q3	$26.7K	Buy	319 +161	+102%	+$12.3K	0.02%	120
2024 Q2	$10.8K	Sell	158 -6	-4%	-$400	0.01%	186
2024 Q1	$12K	Buy	164 +16	+11%	+$1.23K	0.01%	167
2023 Q4	$11.1K	Buy	+148	New	+$11.5K	0.01%	111

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Valued Wealth Advisors's GILD Position: Q2 2026 in Review

Valued Wealth Advisors reduced its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, selling an estimated $2.11K and leaving 652 shares worth $82.4K. The position accounts for 0.03% of the portfolio, ranked #83.

Valued Wealth Advisors first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $93.1K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Valued Wealth Advisors held 652 shares of Gilead Sciences worth $82.4K as of Q2 2026.
Valued Wealth Advisors sold 16 Gilead Sciences shares in Q2 2026, an estimated $2.11K.
Gilead Sciences made up 0.03% of Valued Wealth Advisors's portfolio in Q2 2026, its #83 holding.
Valued Wealth Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Valued Wealth Advisors's Gilead Sciences position peaked at $93.1K in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.